J01XE01 - Nitrofurantoin |
Porphyrinogenic |
P |
Rationale
Hydantoin derivative. Associated with attacks. Several references warn against it.
Chemical description
Nitrofuran derivative used in urinary tract infections. Between 30% and 50% of the dose is excreted in urine in unchanged form. No further data on metabolism or CYP interaction.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| 1. | Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
|
9074793 |
| Drug reference publications | ||
| 2. | Martindale: The complete drug reference. Pharmaceutical Press.
Sweetman SC, editor.
|
|
| Porphyria Drug Lists | ||
| 3. | Australian List
Australian Porphyria Association No longer maintained
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
| Other sources | ||
| 5. | Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
|
|
Tradenames